Open access
Sep 2026
Ogataea Yeast Platform for Recombinant Porcine Interferon-Alpha 1 Production: Toward Alternative Biotherapeutics for Swine Health Management
Based on the proof-of-concept results in this study, the OP39 platform can be further developed into a viable, full freedom-to-operate system for local or regional biomanufacturing of biologically active veterinary therapeutics to support livestock health management.
Benjamas Liwnaree, Thorntun Deangphare, C. Assana et al.
· Microorganisms · 0 citations